Publication
Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.
Weranga Rajapaksha, Preethi Eldi, Todd A Gillam, Anton Blencowe, Sanjay Garg, Hugo Albrecht, Riya Khetan
International journal of nanomedicineJan 1, 2026PMID 42732377doi:10.2147/IJN.S633450 PMC13570424Journal ArticleReviewpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 14, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260914-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Ovarian cancer remains highly lethal due to late diagnosis, frequent recurrence, and rapid development of resistance to platinum-based chemotherapy. Although rational drug combinations targeting multiple oncogenic pathways hold promise, their clinical utility is often compromised by dose-limiting…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.